检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.

Catrin Heim,Laura M Moser, Herman Kreyenberg,Halvard B Bonig,Torsten Tonn,Winfried S Wels,Elise Gradhand,Evelyn Ullrich,Michael T Meister,Marian Groot Koerkamp,Frank C P Holstege,Jarno Drost,Jan-Henning Klusmann,Peter Bader,Michael Merker,Eva Rettinger

Frontiers in immunology（2023）

引用 0|浏览10
暂无评分
摘要
These findings encourage further development of NK-92/5.28.z cells as off-the-shelf immunotherapy for the treatment of metastatic RMS.
更多
查看译文
关键词
ERBB2 (HER2/neu), rhabdomyosarcoma, chimeric antigen receptor, xenograft, cancer immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要